Promega Introduces ONE-Glo + Tox Luciferase Reporter and Cell Viability Assays for Improved Reporter Gene Expression Analysis.

29 Aug 2011

Promega Corporation have announced the launch of ONE-Glo™ + Tox Assay, for improved analysis of reporter gene expression in the context of cell health. The assay combines luciferase chemistry with a cell viability marker in a two-step, addition-only process, to enable measurement of cell viability and gene expression in a single well of a plate, negating the need to run parallel assays. By analysing reporter activity in relation to cell viability, false results due to toxicity or changes in cell number can be uncovered.

The first part of the assay is a non lytic fluorescence assay (CellTiter-Fluor™ Cell Viability Assay) that measures the relative number of the live cells in a culture population after experimental manipulation. The CellTiter-Fluor Assay measures a conserved and constitutive protease activity within live cells and therefore serves as a marker of cell viability. The substrate enters intact cells where it is cleaved by the live-cell protease to generate a fluorescent signal proportional to the number of living cells. The second part of the assay uses the ONE-Glo Lucifease Assay System to quantify firefly luciferase reporter gene expression from cells made to express this reporter enzyme.

Ideally suited for high- and ultra high-throughput applications, the volumes of each assay component can be scaled to meet throughput needs and is amenable to automation up to 1, 536-well format. The ONE-Glo + Tox Assay contains a new fluoroluciferin substrate, resulting in a reagent that is more stable and tolerant to sample components. Luminescence can be measured with a microplate reader or CCD imager.

ONE-Glo + Tox Luciferase Reporter and Cell Viability Assay

Promega Corp.

The ONE-Glo™ + Tox Assay combines luciferase assay chemistry with a cell viability marker to better understand reporter gene expression in the context of cell health. The assay uses a two-step, addition-only process to make these measurements in a single well of a plate, negating the need to run parallel assays. The first part of the assay is a nonlytic fluorescence assay (CellTiter-Fluor™ Cell Viability Assay) that measures the relative number of live cells in a culture population after experimental manipulation. The CellTiter-Fluor™ Assay measures a conserved and constitutive protease activity within live cells and therefore serves as a marker of cell viability. The live-cell protease activity is restricted to intact viable cells and is measured using a fluorogenic, cell-permeant peptide substrate (glycylphenylalanyl-aminofluorocoumarin; GF-AFC). The substrate enters intact cells where it is cleaved by the live-cell protease to generate a fluorescent signal proportional to the number of living cells (Figure 1). This live-cell protease becomes inactive upon loss of cell membrane integrity and leakage into the surrounding culture medium. Fluorescence of the free AFC fluorophore is measured with a microplate reader or CCD imager using an excitation wavelength of 380–400nm and emission wavelength of 505nm. The second part of the assay uses the ONE-Glo™ Luciferase Assay System to quantify firefly luciferase reporter gene expression from cells made to express this reporter enzyme (Figure 2). The ONE-Glo™ Luciferase Assay Buffer and ONE-Glo™ Luciferase Assay Substrate, provided with this system, are combined to form the ONE-Glo™ Reagent. Ideally suited for high- and ultrahigh-throughput applications, the ONE-Glo™ Assay contains a new fluoroluciferin substrate, resulting in a reagent that is more stable, more tolerant to sample components, and has less odor than standard luciferase assay reagents. Luminescence is measured with a microplate reader or CCD imager. Features - Benefits • Efficient: Measure cell viability and firefly luciferase gene expression within the same assay well. • Acquire more data by performing two measurements on cells in a single assay well. • Better Biology: Understand reporter gene expression in the context of cell viability. • Easy to Perform: The assay uses a simple sequential “add-mix-read” format (Figure 3). • Flexible and Automation-Friendly: The volumes of each assay component can be scaled to meet throughput needs and is amenable to automation up to 1,536-well format.

(0)

Links

Tags